Zenith Healthcare to absorb Achyut, promoter stake to rise to 45.8%
Nano-cap with ₹7.42 cr net worth merges with ₹35.06 cr entity. Share count jumps from 5.37 cr to 62.81 cr.
What's new
- Zenith board approved amalgamation with Achyut Healthcare, net worth ₹35.06 cr vs Zenith's ₹7.42 cr.
- Share swap ratio: 119 Zenith shares for every 50 Achyut shares; post-merger share count jumps from 5.37 cr to 62.81 cr.
- Promoter holding to rise to 45.8% from 28.74%, strengthening control.
Why this matters
This is not a routine merger of near-peers. Zenith, with a market cap of ₹17 cr and trailing revenue declining 23.4%, is absorbing a company with ₹35 cr in net worth. Post-merger, the business may look fundamentally different, with access to Achyut's regulated export markets. But the massive dilution means current shareholders see their stake shrink proportionately. For a stock trading at 3477x P/E, this could spur a re-rating or confusion. The decisive factor will be Achyut's profitability and how the merged entity performs.
What we're watching
- NCLT approval timeline — any delays could unsettle the stock.
- Revenue and earnings track record of Achyut; the filing gives net worth but not profit numbers.
- How the market absorbs the dilution re-rating: will the stock adjust before or after the scheme is effective?
The full read
Zenith Healthcare has approved a scheme to merge Achyut Healthcare into itself. The numbers are stark: Zenith's market cap is ₹17 cr, its net worth ₹7.42 cr. Achyut brings in ₹35.06 cr of net worth and ₹38.09 cr in assets. To accommodate Achyut's shareholders, Zenith will issue over 57 crore new shares, increasing total from 5.37 crore to 62.81 crore shares. The exchange ratio: 119 Zenith shares for every 50 Achyut shares. Post-merger, promoter holding climbs to 45.8% from 28.74%. For a company with declining revenue (-23.4% trailing) and negligible profitability (P/E 3477x), this is a bet that Achyut's manufacturing and export access will reset the narrative. The deal needs NCLT sanction. Until then, the stock is priced for a transformation that could either create value or complicate a struggling nano-cap further.
Questions answered
- Why is Zenith amalgamating Achyut?
- The board believes the merger will streamline operations, enhance manufacturing capabilities, and provide access to regulated export markets. Achyut is significantly larger, so the combined entity will have a much larger balance sheet.
- How does the share swap work?
- For every 50 shares of Achyut, shareholders will receive 119 shares of Zenith. This implies issuance of over 57 crore new Zenith shares, increasing total shares from 5.37 crore to 62.81 crore.
- What happens to promoter holding after the merger?
- Promoter holding in the listed entity will increase to 45.8% from 28.74%, giving them stronger control.
- When will the merger be effective?
- It is subject to approval from the NCLT and shareholders. The board has already approved the scheme, but regulatory and shareholder nods are pending.